×
About 100 results

ALLMedicine™ Acute Myelomonocytic Leukemia Center

Research & Reviews  36 results

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemi...
https://doi.org/10.1200/JCO.22.00437
Journal of Clinical Oncology : Official Journal of the Am... Itzykson R, Santini V et. al.

Dec 2nd, 2022 - Hydroxyurea (HY) is a reference treatment of advanced myeloproliferative neoplasms. We conducted a randomized phase III trial comparing decitabine (DAC) and HY in advanced myeloproliferative chronic myelomonocytic leukemias (CMML). Newly diagnosed...

Pruritic papules after induction chemotherapy with daunorubicin and cytarabine.
https://doi.org/10.5070/D328357789
Dermatology Online Journal; Simmons E, Foutouhi S et. al.

Oct 20th, 2022 - We present a 65-year-old woman who developed a diffuse pruritic papular eruption after receiving induction chemotherapy with daunorubicin and cytarabine for newly diagnosed acute myelomonocytic leukemia. The rash improved clinically with triamcino...

AML-479 An Atypical Cause for Hearing Loss and Syncope: Leukemia Cutis of the Ear Secon...
https://doi.org/10.1016/S2152-2650(22)01302-7
Clinical Lymphoma, Myeloma & Leukemia; Boland J, Kalola A et. al.

Sep 28th, 2022 - Leukemia cutis is the invasion of leukemic cells into the skin, resulting in identifiable cutaneous lesions. Leukemia cutis is associated with decreased overall survival and may signify the need for more intensive treatment of leukemia. Herein, we...

Breast myeloid sarcoma presenting as a palpable breast lump after allogeneic stem cell ...
https://doi.org/10.1186/s12957-021-02399-9
World Journal of Surgical Oncology; Huang C, Fei S et. al.

Sep 29th, 2021 - Myeloid sarcoma (MS) is a tumor secondary to myeloid leukemia that consists of immature granulocytes with or without mature granulocytes and is a rare extramedullary manifestation of acute myeloid leukemia (AML). We report a case of a 34-year-old ...

Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052012
Medicine Ji J, Li Y et. al.

Apr 14th, 2021 - Pure erythroid leukemia is a rare subcategory of acute myeloid leukemia characterized by predominant immature erythroid population. Its occurrence subsequent to acute myelomonocytic leukemia has not been reported before. We reported this rare case...

see more →

News  4 results

Leukemia Cutis–Associated Leonine Facies and Eyebrow Loss
http://www.mdedge.com/dermatology/article/198141/nonmelanoma-skin-cancer/leukemia-cutis-associated-leonine-facies-and
Philip R. Cohen, MD

Apr 3rd, 2019 - To the Editor: I read with interest the informative Cutis case report by Krooks and Weatherall1 in which the authors not only described the case of a 66-year-old man whose diagnosis of bone marrow biopsy–confirmed acute myeloid leukemia (AML) pres.

Leukemia Cutis–Associated Leonine Facies and Eyebrow Loss
https://www.mdedge.com/dermatology/article/198141/nonmelanoma-skin-cancer/leukemia-cutis-associated-leonine-facies-and
Philip R. Cohen, MD

Apr 3rd, 2019 - To the Editor: I read with interest the informative Cutis case report by Krooks and Weatherall1 in which the authors not only described the case of a 66-year-old man whose diagnosis of bone marrow biopsy–confirmed acute myeloid leukemia (AML) pres.

Antilymphocyte globulin curbs chronic graft-versus-host disease
https://www.mdedge.com/internalmedicine/article/105685/t-cell-lymphomas/antilymphocyte-globulin-curbs-chronic-graft-versus
Jennifer Shepphird

Jan 9th, 2016 - Antilymphocyte globulin (ATG) added to the myeloablative conditioning regimen of patients undergoing allogeneic stem cell transplantation resulted in a lower incidence of chronic graft-versus-host disease (GVHD) compared with conditioning regimens.

Outcomes worse with secondary and therapy-related AML compared with de novo AML
https://www.mdedge.com/hematology-oncology/article/102154/aml/outcomes-worse-secondary-and-therapy-related-aml-compared-de
Jennifer Kelly Shepphird

Aug 24th, 2015 - Clinical outcomes were significantly worse among younger patients with secondary and therapy-related acute myeloid leukemia (sAML and tAML, respectively) compared with de novo disease, suggesting the presence of distinct AML subtypes, in a study p.

see more →